カテゴリー： Market Monitor Global, 世界, 医療/バイオ

血液内科用治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Hematology Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5604）

◆商品コード：MMG23JU5604
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Hematology Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの血液内科用治療薬市場規模と予測を収録しています。・世界の血液内科用治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の血液内科用治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の血液内科用治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「OTC」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

血液内科用治療薬のグローバル主要企業は、Celgene、 Pfizer、 Roche、 Sanof、 Bristol-Myers Squibb、 AbbVie、 Novartis、 GSK、 Johnson & Johnson、 Takedaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、血液内科用治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の血液内科用治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の血液内科用治療薬市場：タイプ別市場シェア、2022年
・OTC、Rx医薬品

世界の血液内科用治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の血液内科用治療薬市場：用途別市場シェア、2022年
・病院、ドラッグストア、その他

世界の血液内科用治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の血液内科用治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における血液内科用治療薬のグローバル売上、2018年-2023年
・主要企業における血液内科用治療薬のグローバル売上シェア、2022年
・主要企業における血液内科用治療薬のグローバル販売量、2018年-2023年
・主要企業における血液内科用治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Celgene、 Pfizer、 Roche、 Sanof、 Bristol-Myers Squibb、 AbbVie、 Novartis、 GSK、 Johnson & Johnson、 Takeda

*************************************************************

・調査・分析レポートの概要
血液内科用治療薬市場の定義
市場セグメント
世界の血液内科用治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の血液内科用治療薬市場規模
世界の血液内科用治療薬市場規模：2022年 VS 2029年
世界の血液内科用治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの血液内科用治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の血液内科用治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：OTC、Rx医薬品
血液内科用治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、ドラッグストア、その他
血液内科用治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別血液内科用治療薬市場規模 2022年と2029年
地域別血液内科用治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Celgene、 Pfizer、 Roche、 Sanof、 Bristol-Myers Squibb、 AbbVie、 Novartis、 GSK、 Johnson & Johnson、 Takeda
...

In this report, we study the drugs for Hematology. Hematology is the science or study of blood, blood-forming organs and blood diseases. In the medical field, hematology includes the treatment of blood disorders and malignancies, including types of hemophilia, leukemia, lymphoma and sickle-cell anemia.
This report aims to provide a comprehensive presentation of the global market for Hematology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Drugs. This report contains market size and forecasts of Hematology Drugs in global, including the following market information:
Global Hematology Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hematology Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hematology Drugs companies in 2022 (%)
The global Hematology Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
OTC Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hematology Drugs include Celgene, Pfizer, Roche, Sanof, Bristol-Myers Squibb, AbbVie, Novartis, GSK and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hematology Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematology Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hematology Drugs Market Segment Percentages, by Type, 2022 (%)
OTC
Rx Drugs
Global Hematology Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hematology Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Drugs Store
Other
Global Hematology Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hematology Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hematology Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hematology Drugs revenues share in global market, 2022 (%)
Key companies Hematology Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hematology Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celgene
Pfizer
Roche
Sanof
Bristol-Myers Squibb
AbbVie
Novartis
GSK
Johnson & Johnson
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hematology Drugs, market overview.
Chapter 2: Global Hematology Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Hematology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hematology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hematology Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Hematology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hematology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hematology Drugs Overall Market Size
2.1 Global Hematology Drugs Market Size: 2022 VS 2029
2.2 Global Hematology Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hematology Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Hematology Drugs Players in Global Market
3.2 Top Global Hematology Drugs Companies Ranked by Revenue
3.3 Global Hematology Drugs Revenue by Companies
3.4 Global Hematology Drugs Sales by Companies
3.5 Global Hematology Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hematology Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hematology Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hematology Drugs Players in Global Market
3.8.1 List of Global Tier 1 Hematology Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Hematology Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hematology Drugs Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type – Global Hematology Drugs Revenue & Forecasts
4.2.1 By Type – Global Hematology Drugs Revenue, 2018-2023
4.2.2 By Type – Global Hematology Drugs Revenue, 2024-2029
4.2.3 By Type – Global Hematology Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Hematology Drugs Sales & Forecasts
4.3.1 By Type – Global Hematology Drugs Sales, 2018-2023
4.3.2 By Type – Global Hematology Drugs Sales, 2024-2029
4.3.3 By Type – Global Hematology Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Hematology Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hematology Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application – Global Hematology Drugs Revenue & Forecasts
5.2.1 By Application – Global Hematology Drugs Revenue, 2018-2023
5.2.2 By Application – Global Hematology Drugs Revenue, 2024-2029
5.2.3 By Application – Global Hematology Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Hematology Drugs Sales & Forecasts
5.3.1 By Application – Global Hematology Drugs Sales, 2018-2023
5.3.2 By Application – Global Hematology Drugs Sales, 2024-2029
5.3.3 By Application – Global Hematology Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Hematology Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hematology Drugs Market Size, 2022 & 2029
6.2 By Region – Global Hematology Drugs Revenue & Forecasts
6.2.1 By Region – Global Hematology Drugs Revenue, 2018-2023
6.2.2 By Region – Global Hematology Drugs Revenue, 2024-2029
6.2.3 By Region – Global Hematology Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Hematology Drugs Sales & Forecasts
6.3.1 By Region – Global Hematology Drugs Sales, 2018-2023
6.3.2 By Region – Global Hematology Drugs Sales, 2024-2029
6.3.3 By Region – Global Hematology Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hematology Drugs Revenue, 2018-2029
6.4.2 By Country – North America Hematology Drugs Sales, 2018-2029
6.4.3 US Hematology Drugs Market Size, 2018-2029
6.4.4 Canada Hematology Drugs Market Size, 2018-2029
6.4.5 Mexico Hematology Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hematology Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Hematology Drugs Sales, 2018-2029
6.5.3 Germany Hematology Drugs Market Size, 2018-2029
6.5.4 France Hematology Drugs Market Size, 2018-2029
6.5.5 U.K. Hematology Drugs Market Size, 2018-2029
6.5.6 Italy Hematology Drugs Market Size, 2018-2029
6.5.7 Russia Hematology Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Hematology Drugs Market Size, 2018-2029
6.5.9 Benelux Hematology Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hematology Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Hematology Drugs Sales, 2018-2029
6.6.3 China Hematology Drugs Market Size, 2018-2029
6.6.4 Japan Hematology Drugs Market Size, 2018-2029
6.6.5 South Korea Hematology Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Hematology Drugs Market Size, 2018-2029
6.6.7 India Hematology Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hematology Drugs Revenue, 2018-2029
6.7.2 By Country – South America Hematology Drugs Sales, 2018-2029
6.7.3 Brazil Hematology Drugs Market Size, 2018-2029
6.7.4 Argentina Hematology Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hematology Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hematology Drugs Sales, 2018-2029
6.8.3 Turkey Hematology Drugs Market Size, 2018-2029
6.8.4 Israel Hematology Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Hematology Drugs Market Size, 2018-2029
6.8.6 UAE Hematology Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Celgene
7.1.1 Celgene Company Summary
7.1.2 Celgene Business Overview
7.1.3 Celgene Hematology Drugs Major Product Offerings
7.1.4 Celgene Hematology Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Celgene Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Hematology Drugs Major Product Offerings
7.2.4 Pfizer Hematology Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Hematology Drugs Major Product Offerings
7.3.4 Roche Hematology Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Sanof
7.4.1 Sanof Company Summary
7.4.2 Sanof Business Overview
7.4.3 Sanof Hematology Drugs Major Product Offerings
7.4.4 Sanof Hematology Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Sanof Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Hematology Drugs Major Product Offerings
7.5.4 Bristol-Myers Squibb Hematology Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Hematology Drugs Major Product Offerings
7.6.4 AbbVie Hematology Drugs Sales and Revenue in Global (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Hematology Drugs Major Product Offerings
7.7.4 Novartis Hematology Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 GSK
7.8.1 GSK Company Summary
7.8.2 GSK Business Overview
7.8.3 GSK Hematology Drugs Major Product Offerings
7.8.4 GSK Hematology Drugs Sales and Revenue in Global (2018-2023)
7.8.5 GSK Key News & Latest Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Company Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Hematology Drugs Major Product Offerings
7.9.4 Johnson & Johnson Hematology Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Johnson & Johnson Key News & Latest Developments
7.10 Takeda
7.10.1 Takeda Company Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Hematology Drugs Major Product Offerings
7.10.4 Takeda Hematology Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Takeda Key News & Latest Developments
8 Global Hematology Drugs Production Capacity, Analysis
8.1 Global Hematology Drugs Production Capacity, 2018-2029
8.2 Hematology Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Hematology Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hematology Drugs Supply Chain Analysis
10.1 Hematology Drugs Industry Value Chain
10.2 Hematology Drugs Upstream Market
10.3 Hematology Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hematology Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Hematology Drugs in Global Market
Table 2. Top Hematology Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hematology Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hematology Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Hematology Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Hematology Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hematology Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Hematology Drugs Product Type
Table 9. List of Global Tier 1 Hematology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hematology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Hematology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hematology Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hematology Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hematology Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Hematology Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Hematology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hematology Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hematology Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hematology Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Hematology Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Hematology Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hematology Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hematology Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hematology Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Hematology Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Hematology Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hematology Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hematology Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Hematology Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Hematology Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hematology Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hematology Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Hematology Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Hematology Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hematology Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hematology Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Hematology Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Hematology Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hematology Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hematology Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Hematology Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Hematology Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hematology Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hematology Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Hematology Drugs Sales, (K Units), 2024-2029
Table 46. Celgene Company Summary
Table 47. Celgene Hematology Drugs Product Offerings
Table 48. Celgene Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Celgene Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Hematology Drugs Product Offerings
Table 52. Pfizer Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Hematology Drugs Product Offerings
Table 56. Roche Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Sanof Company Summary
Table 59. Sanof Hematology Drugs Product Offerings
Table 60. Sanof Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Sanof Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Hematology Drugs Product Offerings
Table 64. Bristol-Myers Squibb Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. AbbVie Company Summary
Table 67. AbbVie Hematology Drugs Product Offerings
Table 68. AbbVie Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. AbbVie Key News & Latest Developments
Table 70. Novartis Company Summary
Table 71. Novartis Hematology Drugs Product Offerings
Table 72. Novartis Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Novartis Key News & Latest Developments
Table 74. GSK Company Summary
Table 75. GSK Hematology Drugs Product Offerings
Table 76. GSK Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. GSK Key News & Latest Developments
Table 78. Johnson & Johnson Company Summary
Table 79. Johnson & Johnson Hematology Drugs Product Offerings
Table 80. Johnson & Johnson Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Johnson & Johnson Key News & Latest Developments
Table 82. Takeda Company Summary
Table 83. Takeda Hematology Drugs Product Offerings
Table 84. Takeda Hematology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Takeda Key News & Latest Developments
Table 86. Hematology Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Hematology Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Hematology Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Hematology Drugs Production by Region, 2024-2029 (K Units)
Table 90. Hematology Drugs Market Opportunities & Trends in Global Market
Table 91. Hematology Drugs Market Drivers in Global Market
Table 92. Hematology Drugs Market Restraints in Global Market
Table 93. Hematology Drugs Raw Materials
Table 94. Hematology Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Hematology Drugs Downstream
Table 96. Hematology Drugs Downstream Clients in Global Market
Table 97. Hematology Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hematology Drugs Segment by Type in 2022
Figure 2. Hematology Drugs Segment by Application in 2022
Figure 3. Global Hematology Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hematology Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hematology Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Hematology Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hematology Drugs Revenue in 2022
Figure 9. By Type - Global Hematology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hematology Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hematology Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Hematology Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Hematology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hematology Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hematology Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Hematology Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Hematology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hematology Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hematology Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hematology Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Hematology Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hematology Drugs Sales Market Share, 2018-2029
Figure 23. US Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hematology Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hematology Drugs Sales Market Share, 2018-2029
Figure 28. Germany Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hematology Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hematology Drugs Sales Market Share, 2018-2029
Figure 37. China Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hematology Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hematology Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hematology Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hematology Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hematology Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hematology Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Hematology Drugs by Region, 2022 VS 2029
Figure 54. Hematology Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 血液内科用治療薬の世界市場見通し2023年-2029年(Hematology Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

血液内科用治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp